Morgane Lemasson1,2,3,4, Julie Haesebaert4, Louis Rochette4, Eric Pelletier4, Alain Lesage1,2,3,4, Simon Patry1,2. 1. 1 Centre d'Excellence en Électroconvulsivothérapie du Québec, Institut universitaire en santé mentale de Montréal, Montreal, Quebec. 2. 2 Department of Psychiatry, University of Montreal, Montreal. Quebec. 3. 3 Centre de recherche de l'Institut universitaire en santé mentale de Montréal, Montreal, Quebec. 4. 4 Bureau d'information et d'études en santé des populations, Institut national de santé publique du Québec, Quebec, Quebec.
Abstract
OBJECTIVE: As part of a quality improvement process, we propose a model of routinely monitoring electroconvulsive therapy (ECT) in Canadian provinces using linked health administrative databases to generate provincial periodic reports, influence policy, and standardise ECT practices. METHODS: ECT practice in Quebec was studied from 1996 to 2013, using longitudinal data from the Quebec Integrated Chronic Disease Surveillance System of the Institut National de Santé Publique du Québec, which links 5 health administrative databases. The population included all persons, aged 18 y and over, eligible for the health insurance registry, who received an ECT treatment at least once during the year. RESULTS: Among recorded cases, 75% were identified by physician claims and hospitalisation files, 19% exclusively by physician claims, and 6% by hospitalisation files. From 1996 to 2013, 8,149 persons in Quebec received ECT with an annual prevalence rate of 13 per 100,000. A decline was observed, which was more pronounced in women and in older persons. On average, each patient received 9.7 treatments of ECT annually. The proportion of acute ECT decreased whereas maintenance treatment proportions increased. A wide variation in the use of ECT was observed among regions and psychiatrists. CONCLUSION: This study demonstrates the profitable use of administrative data to monitor ECT use in Quebec, and provides a reliable method that could be replicated in other Canadian provinces. Although Quebec has one of the lowest utilisation rates reported in industrialized countries, regional disparities highlighted the need for a deeper examination of the quality and monitoring of ECT care and services.
OBJECTIVE: As part of a quality improvement process, we propose a model of routinely monitoring electroconvulsive therapy (ECT) in Canadian provinces using linked health administrative databases to generate provincial periodic reports, influence policy, and standardise ECT practices. METHODS: ECT practice in Quebec was studied from 1996 to 2013, using longitudinal data from the Quebec Integrated Chronic Disease Surveillance System of the Institut National de Santé Publique du Québec, which links 5 health administrative databases. The population included all persons, aged 18 y and over, eligible for the health insurance registry, who received an ECT treatment at least once during the year. RESULTS: Among recorded cases, 75% were identified by physician claims and hospitalisation files, 19% exclusively by physician claims, and 6% by hospitalisation files. From 1996 to 2013, 8,149 persons in Quebec received ECT with an annual prevalence rate of 13 per 100,000. A decline was observed, which was more pronounced in women and in older persons. On average, each patient received 9.7 treatments of ECT annually. The proportion of acute ECT decreased whereas maintenance treatment proportions increased. A wide variation in the use of ECT was observed among regions and psychiatrists. CONCLUSION: This study demonstrates the profitable use of administrative data to monitor ECT use in Quebec, and provides a reliable method that could be replicated in other Canadian provinces. Although Quebec has one of the lowest utilisation rates reported in industrialized countries, regional disparities highlighted the need for a deeper examination of the quality and monitoring of ECT care and services.
Authors: Nicholas John Delva; Peter Graf; Simon Patry; Caroline Gosselin; Roumen Milev; Ian Gilron; Barry Martin; James Stuart Lawson; Murray Enns; Mark Jewell; Peter Chan Journal: J ECT Date: 2011-12 Impact factor: 3.635
Authors: C Blais; S Jean; C Sirois; L Rochette; C Plante; I Larocque; M Doucet; G Ruel; M Simard; P Gamache; D Hamel; D St-Laurent; V Emond Journal: Chronic Dis Inj Can Date: 2014-11
Authors: Jari Tiihonen; Ellenor Mittendorfer-Rutz; Minna Torniainen; Kristina Alexanderson; Antti Tanskanen Journal: Am J Psychiatry Date: 2015-12-07 Impact factor: 18.112
Authors: Peter Chan; Peter Graf; Murray Enns; Nicholas Delva; Ian Gilron; J Stuart Lawson; Caroline Gosselin; Simon Patry; Roumen Milev; Mark Jewell; Barry Martin Journal: Can J Psychiatry Date: 2012-10 Impact factor: 4.356
Authors: Charles H Kellner; David C Kaicher; Hiya Banerjee; Rebecca G Knapp; Rachael J Shapiro; Mimi C Briggs; Rosa M Pasculli; Dennis M Popeo; Gabriella M Ahle; Lauren S Liebman Journal: J ECT Date: 2015-03 Impact factor: 3.635
Authors: Tyler S Kaster; Daniel M Blumberger; Tara Gomes; Rinku Sutradhar; Zafiris J Dasklakis; Duminda N Wijeysundera; Simone N Vigod Journal: Can J Psychiatry Date: 2020-07-02 Impact factor: 4.356